Reports Q1 revenue $237.6M, consensus $193.35M. Cash and cash equivalents were $110.8M as of March 31, which does not include the $50m upfront payment from Merck that was received in April.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on OPK:
- OPKO Health Reports First Quarter 2023 Business Highlights and Financial Results
- OPKO Health to Report First Quarter 2023 Financial Results on May 3, 2023
- Opko Health management to meet virtually with Piper Sandler
- Opko Health Surges as Merck Considers Deal
- Opko Health enters exclusive worldwide license agreement with Merck